NCT00280852已完成不适用
A Retrospective Review of Multimodality Management of Anaplastic Thyroid Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5
- 试验地点
- 1
研究概览
简要总结
To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •anaplastic thyroid cancer treated with multimodality treatment
排除标准
- •differentiated thyroid cancer
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Multimodality Treatment Including Curative Resection of Advanced NSCLCAdvanced Non-small-cell Lung CancerNCT04455984Medical University of Vienna190
已完成
3 期
rhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC)Differentiated Thyroid CancerNCT04964284Suzhou Zelgen Biopharmaceuticals Co.,Ltd390
已完成
3 期
A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.Differentiated Thyroid CancerNCT00295763Genzyme, a Sanofi Company61
进行中（未招募）
不适用
ew therapeutic approaches for anaplastic thyroid cancer: assessment of the benefit-risk profile of the combination valproic acid-paclitaxel. - NDEUCTR2008-005221-11-ITAZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
未知
2 期
A phase II study for anaplastic thyroid canceranaplastic thyroid cancerJPRN-UMIN000000482agoya university hospital20